The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
- PMID: 26070547
- DOI: 10.1007/s00213-015-3954-6
The subchronic phencyclidine rat model: relevance for the assessment of novel therapeutics for cognitive impairment associated with schizophrenia
Abstract
Rationale: Current treatments for schizophrenia have modest, if any, efficacy on cognitive dysfunction, creating a need for novel therapies. Their development requires predictive animal models. The N-methyl-D-aspartate (NMDA) hypothesis of schizophrenia indicates the use of NMDA antagonists, like subchronic phencyclidine (scPCP) to model cognitive dysfunction in adult animals.
Objectives: The objective of this study was to assess the scPCP model by (1) reviewing published findings of scPCP-induced neurochemical changes and effects on cognitive tasks in adult rats and (2) comparing findings from a multi-site study to determine scPCP effects on standard and touchscreen cognitive tasks.
Methods: Across four research sites, the effects of scPCP (typically 5 mg/kg twice daily for 7 days, followed by at least 7-day washout) in adult male Lister Hooded rats were studied on novel object recognition (NOR) with 1-h delay, acquisition and reversal learning in Morris water maze and touchscreen-based visual discrimination.
Results: Literature findings showed that scPCP impaired attentional set-shifting (ASST) and NOR in several labs and induced a variety of neurochemical changes across different labs. In the multi-site study, scPCP impaired NOR, but not acquisition or reversal learning in touchscreen or water maze. Yet, this treatment regimen induced locomotor hypersensitivity to acute PCP until 13-week post-cessation.
Conclusions: The multi-site study confirmed that scPCP impaired NOR and ASST only and demonstrated the reproducibility and usefulness of the touchscreen approach. Our recommendation, prior to testing novel therapeutics in the scPCP model, is to be aware that further work is required to understand the neurochemical changes and specificity of the cognitive deficits.
Keywords: Adult rat; Cognition; Schizophrenia; Subchronic phencyclidine; Touchscreen; Visual discrimination; Water maze.
Similar articles
-
Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.Psychopharmacology (Berl). 2015 Nov;232(21-22):3883-97. doi: 10.1007/s00213-015-4018-7. Epub 2015 Jul 21. Psychopharmacology (Berl). 2015. PMID: 26194915
-
Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.Psychopharmacology (Berl). 2016 Feb;233(4):649-60. doi: 10.1007/s00213-015-4137-1. Epub 2015 Nov 12. Psychopharmacology (Berl). 2016. PMID: 26558619
-
Handling prevents and reverses cognitive deficits induced by sub-chronic phencyclidine in a model for schizophrenia in rats.Physiol Behav. 2023 May 1;263:114117. doi: 10.1016/j.physbeh.2023.114117. Epub 2023 Feb 11. Physiol Behav. 2023. PMID: 36781093
-
Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review.Curr Top Behav Neurosci. 2016;29:403-428. doi: 10.1007/7854_2015_403. Curr Top Behav Neurosci. 2016. PMID: 26510740 Review.
-
Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.Pharmacol Ther. 2010 Dec;128(3):419-32. doi: 10.1016/j.pharmthera.2010.07.004. Epub 2010 Aug 10. Pharmacol Ther. 2010. PMID: 20705091 Review.
Cited by
-
TPA-023 attenuates subchronic phencyclidine-induced declarative and reversal learning deficits via GABAA receptor agonist mechanism: possible therapeutic target for cognitive deficit in schizophrenia.Neuropsychopharmacology. 2018 Nov;43(12):2468-2477. doi: 10.1038/s41386-018-0160-3. Epub 2018 Jul 23. Neuropsychopharmacology. 2018. PMID: 30093697 Free PMC article.
-
An Overview of Animal Models Related to Schizophrenia.Can J Psychiatry. 2019 Jan;64(1):5-17. doi: 10.1177/0706743718773728. Epub 2018 May 9. Can J Psychiatry. 2019. PMID: 29742910 Free PMC article. Review.
-
The neural basis of reversal learning: An updated perspective.Neuroscience. 2017 Mar 14;345:12-26. doi: 10.1016/j.neuroscience.2016.03.021. Epub 2016 Mar 12. Neuroscience. 2017. PMID: 26979052 Free PMC article. Review.
-
Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.Transl Psychiatry. 2021 Apr 29;11(1):253. doi: 10.1038/s41398-021-01371-1. Transl Psychiatry. 2021. PMID: 33927180 Free PMC article.
-
Effects of chronic stress on cognitive function - From neurobiology to intervention.Neurobiol Stress. 2024 Sep 2;33:100670. doi: 10.1016/j.ynstr.2024.100670. eCollection 2024 Nov. Neurobiol Stress. 2024. PMID: 39295772 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical